ClinicalTrials.gg
Not yet recruitingNCT07844330LipoxAPPUpdated Sep 28, 2026

Nutritional Responses to Acute Exercise Performed on the LipoxMax in Obese Adolescents

An interventional study of The participants in this study are adolescents with obesity (with a Body Mass Index above the 95th percentile on international growth charts) in Weight Gain, Weight Loss and Eating Attitudes, sponsored by Centre Hospitalier Emile Roux. Not yet recruiting at 1 site in France. Open to participants aged 12 Years to 16 Years. Per ClinicalTrials.gov, last updated 2026-09-28.

Sponsored by Centre Hospitalier Emile Roux · Not applicable, Interventional, and Other

How we know

Updated Sep 28, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
18
Allocation
Not applicable
Ages
12 Years to 16 Years
Sex
All
01

Study summary

Primarily over the past 20 years, it has been shown that physical activity not only leads to energy expenditure but can also indirectly influence energy intake and feelings of hunger in both lean and obese adults, suggesting that physical activity has a dual effect on energy balance.

Studies in children and adolescents are less common, but it now seems clear that their energy intake is affected by physical exercise ) depending on their weight status.

Read the detailed description

Our team has indeed demonstrated the appetite-suppressing effects of moderate- to vigorous-intensity exercise (>65% of maximum capacity) in obese adolescents, regardless of gender. While research conducted to date has primarily focused on identifying the characteristics of exercise that can influence food intake in these adolescents-such as the type, intensity, or duration of exercise-it appears that, beyond physical exercise itself, the energy substrates utilized during exercise may play a crucial role.

In adults-whether of normal weight, overweight, or obese-the scientific literature highlights not only the energy expenditure generated by physical exercise but also the vital role played by the type of energy substrate used to fuel this expenditure. Indeed, while physical exercise that primarily promotes lipid oxidation does not appear to significantly impact eating behavior at the next meal, carbohydrate utilization, on the other hand, appears to have a rather appetite-stimulating effect. Although this nutritional impact of the types of energy substrates utilized during physical exercise is crucial for better guiding our recommendations for adapted physical activity, it remains unexplored in adolescents at this time. Recently, based on a secondary analysis, our team suggested a positive correlation between energy expenditure during a 30-minute cycling exercise and subsequent food intake in adolescents with obesity. In that study, carbohydrate oxidation in particular showed a positive relationship with the adolescents' food intake at the next meal. These preliminary results led to a study dedicated to this question; however, that study unfortunately did not replicate this relationship and appears to indicate that carbohydrate utilization during acute exercise is not involved in short-term dietary regulation in these adolescents.

However, that study had focused its design on an exercise regimen that promotes carbohydrate utilization, and the potential role of fat oxidation remains unexplored in this population. In overweight adults, Javernaud and colleagues previously demonstrated that exercise targeting the maximum lipid oxidation point (known as Lipoxmax) reduced feelings of hunger in the hours following the workout while improving participants' satiety. While prescribing physical exercise as a key component of pediatric obesity management is considered essential for optimizing treatment outcomes, the potential impact of exercise performed at Lipoxmax on food intake remains unexplored in this population.

Thus, in this context, the objective of this study is to explore the effects of a single session of exercise performed at the maximum lipid oxidation point (Lipoxmax) on dietary control in adolescents with obesity.

02

Conditions studied

  • Weight Gain
  • Weight Loss
  • Eating Attitudes
  • Obese Adolescents
03

In context

Weight Gain

317 studies on the registry are indexed under Weight Gain; 48 are open to participants now.

This study's planned enrollment of 18 is below the median of 83 across 251 interventional studies indexed under Weight Gain.

Browse Weight Gain studies →

Lead sponsor

Centre Hospitalier Emile Roux is the lead sponsor of 20 studies on the registry; 15 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
12 Years to 16 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adolescents aged 12 to 16 (inclusive), at Tanner stage 3-5,
  • With obesity defined as a (BMI) above the 95th percentile according to international growth charts,
  • Adolescents enrolled in the social security system or an equivalent program,
  • Adolescents who have been informed and have provided written consent to participate in the study

Exclusion criteria

Exclusion Criteria:

  • Refusal to participate in the study,
  • Refusal of consent by legal guardians,
  • Regular use of tobacco or alcohol,
  • Special dietary restrictions,
  • Participation in regular and intense physical and sports activities,
  • Medical or surgical history deemed by the investigator to be incompatible with the study,
  • Diabetes, or any other condition that limits the application of either strategy in the trial,
  • Adolescents currently following a calorie-restricted diet or a weight-loss program involving physical activity at the time of enrollment or within the past 6 months,
  • Taking medications that may interfere with the study results,
  • Adolescents with cardiovascular problems; this refers to participants with a history of cardiovascular and/or neurovascular disease, as well as those with cardiovascular and/or neurovascular risk factors (excluding obesity or being overweight),
  • Surgery within the previous 3 months,
  • Adolescents who are currently excluded from another study,
  • Pregnant or breastfeeding adolescents,
  • Adolescents under guardianship, conservatorship, or judicial protection,
  • Parents under conservatorship, guardianship, or judicial protection
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
18 participants (estimated)

Study arms

  • Other
    Intervention

    The participants in this study are adolescents with obesity (with a Body Mass Index above the 95th percentile on international growth charts).

    Other: The participants in this study are adolescents with obesity (with a Body Mass Index above the 95th percentile on international growth charts)

Interventions

  • OtherThe participants in this study are adolescents with obesity (with a Body Mass Index above the 95th percentile on international growth charts)

    This study aims to understand how physical exercise performed at a specific intensity that promotes fat utilization (called LipoxMax) influences food intake, hunger, and food preferences in adolescents with obesity. Following an initial screening visit to verify eligibility criteria and assess dietary habits, participants undergo a measurement visit at Clermont-Ferrand University Hospital, which includes anthropometric assessments (height, weight, waist and hip circumferences), body composition measurements (body fat, muscle mass, bone structure), and a bicycle ergometer test to determine their LipoxMax intensity. The adolescents then undergo two experimental visits at the AME2P laboratory in Clermont-Ferrand, conducted in random order and spaced at least five days apart. At each visit, they arrive having fasted, consume a standardized breakfast, and then rest until 11:00 a.m. They then either rest for 40 minutes (control condition) or perform a 40-minute exercise session at LipoxMax.

06

What researchers measure

Primary outcomes

  1. ad libitum food intake in response to exercise

    Method: Meta-Max Indirect Calorimetry The following will be measured here: energy expenditure in kcal/min based on oxygen consumption, as well as fat and carbohydrate utilization based on the respiratory quotient (VCO2/VO2), in mg/min.

    Time frame: 3 months

Secondary outcomes

  1. Feelings of hunger in response to exercise

    Method: HUNGER SENSATION QUESTIONNAIRE Patients will have to answer 4 questions with answer situated in between "not at all" and "Very much". The questions are: Are you hungry? Do you feel satiated? How much could you eat again? Would you like to eat something?

    Time frame: 3 months

  2. Hedonic response as measured by food liking and wanting

    Their relationship with food will be investigated 15 min before the test meal and then 1 hour after, using the Leeds Foods Preference Questionnaire. The adolescents will be asked to answer a series of questions about their food preferences by selecting their favorite foods from a selection of images during a 10-min computer exercise. During this exercise, they are asked to use a visual analog scale to estimate how much they would like to eat certain foods presented. Based on their choices and the time taken to respond, the LFPQ assesses the adolescents' degree of "liking" and "wanting." The adolescents will be asked to complete this exercise 15 minutes before and after the evening test meal. To avoid influencing food intake at the next meal, the foods presented during the test are not the same as those presented during the meal. As the aim of this exercise is to assess the response of "liking" and "wanting" to food intake, it is necessary to carry it out before and after the meal.

    Time frame: 3 months

07

Study locations

1 site
  • Laboratoire AME2P
    Aubière, 63178, France
08

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Sep 2026; primary completion for Jul 2028, 22 months later.

Of 96 non-industry interventional studies with no phase under Weight Gain, half reached primary completion within 30 months of starting (the median), counting those still running; a quarter within 13 and three quarters within 47. This study's planned 22 months is below that.

Counting every sponsor, half of 102 studies reached it within 25 months; a quarter within 12 and three quarters within 47.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 22, 2026
First posted
Sep 28, 2026
StartEst.
Sep 1, 2026
Primary completionEst.
Jul 1, 2028
CompletionEst.
Sep 30, 2029
Last update
Sep 28, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Sep 28, 2026
Show all 1 update
  1. Sep 28, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

09

Registry details

Key details

Study ID
NCT07844330
Lead sponsor
Centre Hospitalier Emile Roux
Responsible party
Sponsor
First posted
Sep 28, 2026
Start date
Sep 1, 2026 (estimated)
Primary completion
Jul 1, 2028 (estimated)
Completion
Sep 30, 2029 (estimated)
Last update
Sep 28, 2026

Study contacts

David THIVEL
Contact
david.thivel@uca.fr
00 33 4 73405486

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion